Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Sabra Health Care REIT's Debt-to-EBITDA or its related term are showing as below:
MEX:SBRA'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: 5.34 Med: 6.21 Max: 14.71
Current: 6.73
During the past 13 years, the highest Debt-to-EBITDA Ratio of Sabra Health Care REIT was 14.71. The lowest was 5.34. And the median was 6.21.
MEX:SBRA's Debt-to-EBITDA is ranked worse than 52.27% of 572
companies
in the REITs industry
Industry Median: 6.55
vs MEX:SBRA: 6.73
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Sabra Health Care REIT Debt-to-EBITDA Related Terms
Sabra Health Care REIT Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Sabra Health Care REIT's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:SBRA vs NHI, HR, MPT: Debt-to-EBITDA Comparison
For the REIT - Healthcare Facilities subindustry, Sabra Health Care REIT's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sabra Health Care REIT Debt-to-EBITDA vs REITs Industry
For the REITs industry and Real Estate sector, Sabra Health Care REIT's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Sabra Health Care REIT's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Jun. 2026) EBITDA data.
Sabra Health Care REIT (MEX:SBRA) has a Debt-to-EBITDA of 10.74 as of Jun. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Sabra Health Care REIT. This is 73% above median its historical median of 6.21. Over the past decade, Sabra Health Care REIT's Debt-to-EBITDA has ranged from 5.34 to 14.71. According to the industry distribution chart, Sabra Health Care REIT ranks #299 out of 572 companies in the REITs industry, placing it in the top 52.3%.
Is Sabra Health Care REIT's Debt-to-EBITDA too high?
Sabra Health Care REIT's current Debt-to-EBITDA of 10.74 is 73% above median its 10-year median of 6.21. Over the past 10 years, this metric has ranged from a low of 5.34 to a high of 14.71. The REITs industry median Debt-to-EBITDA is 6.55. Sabra Health Care REIT's value of 10.74 is 64% above this industry median. Based on the distribution chart, Sabra Health Care REIT ranks #299 out of 572 companies in the REITs industry, which is below the industry midpoint. Overall, Sabra Health Care REIT has a GF Score™ of 84/100, reflecting its overall financial health beyond just this single metric.
How does Sabra Health Care REIT's Debt-to-EBITDA compare to NHI and HR?
According to the REITs industry distribution chart, Sabra Health Care REIT ranks #299 out of 572 companies for Debt-to-EBITDA. This places Sabra Health Care REIT in the lower half of its industry. The industry median Debt-to-EBITDA is 6.55. Sabra Health Care REIT's value of 10.74 is 64% above this benchmark. Historically, Sabra Health Care REIT's own Debt-to-EBITDA has ranged from 5.34 to 14.71 over the past decade. While the company's 10-year median is 6.21 vs. the industry median of 6.55, Sabra Health Care REIT has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a REITs company?
The median Debt-to-EBITDA among REITs companies is 6.55, based on 572 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sabra Health Care REIT's current Debt-to-EBITDA of 10.74 is 64% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Sabra Health Care REIT. For the REITs industry, the median Debt-to-EBITDA is 6.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sabra Health Care REIT's current Debt-to-EBITDA is 10.74, which is 73% above median its own 10-year median of 6.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sabra Health Care REIT stock overvalued right now?
Sabra Health Care REIT (MEX:SBRA) has a current Debt-to-EBITDA of 10.74. The stock's GF Value™ is MXN333.30, compared to a current price of MXN342.81 — trading 2.9% above its estimated fair value. The current Debt-to-EBITDA is 10.74, which is 73% above median its 10-year median of 6.21 and 64% above the REITs industry median of 6.55. Sabra Health Care REIT's overall GF Score™ is 84/100 with 12 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Sabra Health Care REIT (MEX:SBRA), the current Debt-to-EBITDA is 10.74 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sabra Health Care REIT (MEX:SBRA) Overvalued in 2026?
Based on GuruFocus' analysis, Sabra Health Care REIT stock appears to be overvalued.
The current stock price of MXN342.81 is trading 2.9% above its estimated GF Value™ of MXN333.30.
Key valuation signals for MEX:SBRA:
Debt-to-EBITDA: 10.74 (73% above median its 10-year median of 6.21)
GF Value™: MXN333.30 vs. price of MXN342.81 (2.9% above fair value)
Industry Position: 64% above the REITs median (#299 of 572)
No single metric tells the full story. See the MEX:SBRA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sabra Health Care REIT Inc is a healthcare facility real estate investment trust. The company operates one segment that owns and invests in healthcare real estate. All of the company's revenue is generated in the United States. Sabra's operations consist of nursing facilities, assisted living centers, and mental health facilities.
84GF Score
Get the complete analysis for MEX:SBRA
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:SBRA has been successfully added to your 
